Drugs associated with posterior reversible encephalopathy syndrome, a worldwide signal detection study.

Alexander BalceracKevin BihanDimitri PsimarasBénédicte Lebrun-VignesJoe-Elie SalemNicolas Weiss

Published in: Journal of neurology (2022)

These results will help clinicians identify potential suspected drugs associated with PRES and decide which drug to discontinue and eventually lead to a re-evaluation of drug labels for some molecules.

Keyphrases

drug induced
palliative care
early onset
pulmonary embolism
adverse drug
emergency department
label free